Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone vs Risperidone in Chronic Schizophrenia
NCT00645515Phase 3Terminated
- Sponsor
- Viatris
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ziprasidone in schizophrenia, sponsored by Viatris. Started Jun 2003; status: terminated.
02
Drugs
ziprasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00645515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645515.